|
|
|
Day 1 | Day 2 | Day 3 | Symposium
|
|
Satellite Symposium
| Day 2 - Saturday, April 4, 2009 |
| |
Meeting
Room 301 |
Meeting
Room 302 |
Meeting
Room 303 |
Meeting
Room 304 |
Meeting
Room 305 |
Meeting
Room 306 |
| 1830 - 1930 hrs |
Innogene-Kalbiotech Satellite Symposium |
The Discovery of HPV and Cancer Vaccination
Chair: David COLLINGRIDGE, UK
Speaker: Harald zur HAUSEN, Germany
Speaker: TAY Eng Hseon, Singapore |
Eli Lilly
Satellite Symposium
Integrating chemotherapy and/or targeted agents to maximize survival in NSCLC patients
Speaker : Dr Sunil Verma , Canada |
Abbott Molecular
Satellite Symposium
Patient selection for targeted therapy in gastrointestinal cancer
Chair: Manuel SALTO-TELLEZ, Singapore
Speaker: Eric VAN CUTSEM, Belgium
|
|
|
Sponsored Symposium
| Day 1 - Friday, April 3, 2009 |
1240 - 1340 hrs |
GSK Lunch Symposium (Gallery East, Level 3)
Anti-ErbB2 therapy: Old and new
- Jenny CHANG, USA |
1900 - 2030 hrs |
Pfizer Dinner Symposium (Ballroom 1, Level 2)
Updates in endocrine and targeted therapies in the management of breast cancer
Chair: WONG Nan Soon, Singapore
Speaker: Kathleen PRITCHARD, Canada
Speaker: LEE Soo Chin, Singapore |
| |
| Day 2 - Saturday, April 4, 2009 |
1245 - 1345 hrs |
Pfizer Lunch Symposium (Gallery East, Level 3)
Management of mRCC in the era of targeted therapy
Chair: KONG Hwai Loong
Speaker: TAN Min Han, Singapore
Speaker: Primo N. LARA, Jr, USA
Speaker: TOH Chee Keong, Singapore |
| 1900 - 2100 hrs |
Sponsored Dinner Symposium |
| |
|
**Programme is correct as of 28 March 2009 and is subjected to changes. |
|
Copyright © 2008 Elsevier (Singapore) Pte Ltd. |
|
|
|
